Spatial control of membrane receptor function using ligand nanocalipers

Casaletto, J.B. & McClatchey, A.I. Spatial regulation of receptor tyrosine kinases in development and cancer. Nat. Rev. Cancer 12, 387–400 (2012).

Salaita, K. et al. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science 327, 1380–1385 (2010).

Lohmüller, T. et al. Supported membranes embedded with fixed arrays of gold nanoparticles. Nano Lett. 11, 4912–4918 (2011).

Holmberg, J. et al. Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis. Genes Dev. 19, 462–471 (2005).

Pasquale, E.B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 10, 165–180 (2010).

Miao, H. et al. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 16, 9–20 (2009).

Batlle, E. et al. EphB receptor activity suppresses colorectal cancer progression. Nature 435, 1126–1130 (2005).

Genander, M. et al. Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression. Cell 139, 679–692 (2009).

Bethani, I., Skånland, S.S., Dikic, I. & Acker-Palmer, A. Spatial organization of transmembrane receptor signalling. EMBO J. 29, 2677–2688 (2010).

Davis, S. et al. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266, 816–819 (1994).

Wykosky, J. et al. Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor. Oncogene 27, 7260–7273 (2008).

Stein, E. et al. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 12, 667–678 (1998).

Egea, J. et al. Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function. Neuron 47, 515–528 (2005).

Seeman, N.C. Nanomaterials based on DNA. Annu. Rev. Biochem. 79, 65–87 (2010).

Rothemund, P.W.K. Folding DNA to create nanoscale shapes and patterns. Nature 440, 297–302 (2006).

Högberg, B. & Olin, H. DNA-scaffolded nanoparticle structures. J. Phys. Conf. Ser. 61, 458–462 (2007).

Voigt, N.V. et al. Single-molecule chemical reactions on DNA origami. Nat. Nanotechnol. 5, 200–203 (2010).

Selmi, D.N. et al. DNA-templated protein arrays for single-molecule imaging. Nano Lett. 11, 657–660 (2011).

Rinker, S., Ke, Y., Liu, Y., Chhabra, R. & Yan, H. Self-assembled DNA nanostructures for distance-dependent multivalent ligand-protein binding. Nat. Nanotechnol. 3, 418–422 (2008).

Park, S.H. et al. Programmable DNA self-assemblies for nanoscale organization of ligands and proteins. Nano Lett. 5, 729–733 (2005).

Derr, N.D. et al. Tug-of-war in motor protein ensembles revealed with a programmable DNA origami scaffold. Science 338, 662–665 (2012).

Douglas, S.M., Bachelet, I. & Church, G.M. A logic-gated nanorobot for targeted transport of molecular payloads. Science 335, 831–834 (2012).

Douglas, S.M. et al. Self-assembly of DNA into nanoscale three-dimensional shapes. Nature 459, 414–418 (2009).

Andersen, E.S. et al. Self-assembly of a nanoscale DNA box with a controllable lid. Nature 459, 73–76 (2009).

Abulrob, A. et al. Nanoscale imaging of epidermal growth factor receptor clustering: effects of inhibitors. J. Biol. Chem. 285, 3145–3156 (2010).

Lajoie, P. et al. Plasma membrane domain organization regulates EGFR signaling in tumor cells. J. Cell Biol. 179, 341–356 (2007).

Castro, C.E. et al. A primer to scaffolded DNA origami. Nat. Methods 8, 221–229 (2011).

Söderberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995–1000 (2006).

Pitulescu, M.E. & Adams, R.H. Eph/ephrin molecules—a hub for signaling and endocytosis. Genes Dev. 24, 2480–2492 (2010).

Zhuang, G., Hunter, S., Hwang, Y. & Chen, J. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation. J. Biol. Chem. 282, 2683–2694 (2007).

Hiramoto-Yamaki, N. et al. Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism. J. Cell Biol. 190, 461–477 (2010).

Macrae, M. et al. A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell 8, 111–118 (2005).

Himanen, J.P. et al. Architecture of Eph receptor clusters. Proc. Natl. Acad. Sci. USA 107, 10860–10865 (2010).

Seiradake, E., Harlos, K., Sutton, G., Aricescu, A.R. & Jones, E.Y. An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly. Nat. Struct. Mol. Biol. 17, 398–402 (2010).

Wimmer-Kleikamp, S.H., Janes, P.W., Squire, A., Bastiaens, P.I.H. & Lackmann, M. Recruitment of Eph receptors into signaling clusters does not require ephrin contact. J. Cell Biol. 164, 661–666 (2004).

Mitov, M.I., Greaser, M.L. & Campbell, K.S. GelBandFitter—a computer program for analysis of closely spaced electrophoretic and immunoblotted bands. Electrophoresis 30, 848–851 (2009).

Coffman, K.T. et al. Differential EphA2 epitope display on normal versus malignant cells. Cancer Res. 63, 7907–7912 (2003).